1. Home
  2. KNSA vs RES Comparison

KNSA vs RES Comparison

Compare KNSA & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • RES
  • Stock Information
  • Founded
  • KNSA 2015
  • RES 1984
  • Country
  • KNSA United Kingdom
  • RES United States
  • Employees
  • KNSA N/A
  • RES N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • RES Oilfield Services/Equipment
  • Sector
  • KNSA Health Care
  • RES Energy
  • Exchange
  • KNSA Nasdaq
  • RES Nasdaq
  • Market Cap
  • KNSA 1.7B
  • RES 1.5B
  • IPO Year
  • KNSA 2018
  • RES N/A
  • Fundamental
  • Price
  • KNSA $26.79
  • RES $6.29
  • Analyst Decision
  • KNSA Strong Buy
  • RES Sell
  • Analyst Count
  • KNSA 5
  • RES 3
  • Target Price
  • KNSA $33.60
  • RES $6.25
  • AVG Volume (30 Days)
  • KNSA 283.3K
  • RES 1.7M
  • Earning Date
  • KNSA 10-29-2024
  • RES 10-24-2024
  • Dividend Yield
  • KNSA N/A
  • RES 2.52%
  • EPS Growth
  • KNSA N/A
  • RES N/A
  • EPS
  • KNSA N/A
  • RES 0.55
  • Revenue
  • KNSA $338,930,000.00
  • RES $1,466,934,000.00
  • Revenue This Year
  • KNSA $58.95
  • RES N/A
  • Revenue Next Year
  • KNSA $36.22
  • RES $6.59
  • P/E Ratio
  • KNSA N/A
  • RES $11.51
  • Revenue Growth
  • KNSA 20.69
  • RES N/A
  • 52 Week Low
  • KNSA $14.12
  • RES $5.66
  • 52 Week High
  • KNSA $27.92
  • RES $9.22
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 58.67
  • RES 41.50
  • Support Level
  • KNSA $23.33
  • RES $6.29
  • Resistance Level
  • KNSA $27.35
  • RES $6.95
  • Average True Range (ATR)
  • KNSA 0.89
  • RES 0.24
  • MACD
  • KNSA 0.15
  • RES -0.09
  • Stochastic Oscillator
  • KNSA 86.07
  • RES 0.00

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment consists of pressure pumping, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, and fishing. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

Share on Social Networks: